Disclaimer: All products are for laboratory research only and not for human or animal use or consumption. For in-vitro research by qualified professionals only
$120.00
4 in stock (can be backordered)
Ships today if ordered and paid by 12 PM EST. (Except Saturdays & Sundays)
Due to our rigorous quality control standards and the fragile nature of our products, we cannot accept returns. In the rare occasion that your order arrives with missing, incorrect or damaged items, please email [email protected] for assistance. Our customer support representatives are standing by to ensure that our customers are 100% satisfied with our product quality, customer support and delivery. Cancellations must be requested by email before the order shipment has shipped. Once the order has shipped you may not cancel your order. Please contact us at [email protected] with any questions or concerns that you may have regarding your order. We will do our absolute best to assist you as quickly and satisfactorily as possible.Thank you.
SLU-PP-332 in a 100-count tablet configuration (250mcg per tablet) provides an extended supply of this ERRα/ERRγ agonist designed for prolonged preclinical study protocols requiring consistent daily administration in animal models. Supplied as compressed tablets.
Compound Information:
• Chemical Name: SLU-PP-332
• Target Receptors: ERRα (Estrogen-Related Receptor Alpha), ERRγ (Estrogen-Related Receptor Gamma)
• Molecular Class: Small-molecule nuclear receptor agonist
• Purity: ≥98%
SLU-PP-332 activates estrogen-related receptors that regulate mitochondrial biogenesis and oxidative metabolism gene programs. The 100-tablet format enables researchers to design long-duration chronic administration studies with standardized per-unit dosing across extended experimental timelines.
Research Applications:
• Chronic ERRα/ERRγ activation studies spanning multi-week administration protocols in rodent models
• Assessment of cumulative mitochondrial biogenesis markers following sustained receptor activation
• Long-term oxidative phosphorylation gene expression profiling under consistent agonist exposure
• Time-course evaluation of skeletal muscle fiber-type composition changes during extended treatment periods
• Longitudinal metabolic phenotyping across sequential treatment phases with standardized oral dosing
Storage and Handling:
• Store tablets in sealed container at room temperature (15-25°C) protected from moisture
• Keep in original packaging until use to maintain tablet integrity
• Avoid exposure to excessive humidity or direct light
• Suitable for ambient storage; refrigeration not required
Product Specifications:
• Purity: ≥98%
• Appearance: White to off-white compressed tablets
• Form: Oral tablets
• Quantity: 100 tablets (250mcg each)
FOR RESEARCH USE ONLY. Not intended for human consumption or clinical use. All products are sold strictly for laboratory, educational, and scientific research purposes.